Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetRevenue - OtherRevenue - RentalShares Issued
Ratios

Maxcyte (MXCT) Receivables - Net (2020 - 2025)

Maxcyte (MXCT) has disclosed Receivables - Net for 6 consecutive years, with $3.5 million as the latest value for Q4 2025.

  • Quarterly Receivables - Net fell 25.18% to $3.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.5 million through Dec 2025, down 25.18% year-over-year, with the annual reading at $3.5 million for FY2025, 25.18% down from the prior year.
  • Receivables - Net for Q4 2025 was $3.5 million at Maxcyte, down from $8.3 million in the prior quarter.
  • The five-year high for Receivables - Net was $11.2 million in Q4 2022, with the low at $3.5 million in Q4 2025.
  • Average Receivables - Net over 5 years is $6.6 million, with a median of $6.0 million recorded in 2024.
  • The sharpest move saw Receivables - Net plummeted 48.3% in 2023, then skyrocketed 82.15% in 2025.
  • Over 5 years, Receivables - Net stood at $6.9 million in 2021, then surged by 62.5% to $11.2 million in 2022, then tumbled by 48.3% to $5.8 million in 2023, then dropped by 18.97% to $4.7 million in 2024, then dropped by 25.18% to $3.5 million in 2025.
  • According to Business Quant data, Receivables - Net over the past three periods came in at $3.5 million, $8.3 million, and $5.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.